The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Dow Jones U.S. Basic Materials Index for a single day, not for any other period. The Index seeks to measure the performance of certain companies in the basic materials sector of the U.S. equity market.
- 1 Week
- 1 Month
- 3 Months
- 1 Yr Return
- 5 Yr Return
|Non Classified Equity||0.26%|
Top 10 Holdings
|Symbol||Company Name||% Of Assets|
|LIN||Linde PLC ORD||16.65%|
|APD||Air Products and Chemicals Inc ORD||6.23%|
|ECL||Ecolab Inc ORD||5.71%|
|FCX||Freeport-McMoRan Inc ORD||5.25%|
|NEM||Newmont Corporation ORD||4.77%|
|DOW||Dow Inc ORD||4.72%|
|DD||Dupont De Nemours Inc ORD||3.91%|
|PPG||PPG Industries Inc ORD||3.73%|
|IFF||International Flavors & Fragrances Inc ORD||3.66%|
|CTVA||Corteva Inc ORD||3.40%|
|Name||ProShares:Ult Bas Mat|
|Market Capitalization||55.43 B|
|Total Net Assets||76.10|
|Sub Asset Class||Equity Leverage Funds|
|Number Of Holdings||41|
Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy
Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial
ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.
Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks
Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.
Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel
Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.
Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings
Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.
Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know
Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.
Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix
Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.